Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Wall Street Week Ahead - Apple Leads Packed Earnings Calendar As Investors Eye Tech, Pharma Results
Apple Leads Packed Earnings Calendar As Investors Eye Tech, Pharma Results
Seeking Alpha –

Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs…

econotimes.com - Helena Ward - Sun Pharma Q2 Profit Falls 36.2% as Adjusted Net Profit Rises
Sun Pharma Q2 Profit Falls 36.2% as Adjusted Net Profit Rises
EconoTimes –

Sun Pharmaceutical Industries reported a 36.2% year-over-year drop in second-quarter net profit after exceptional costs, even as revenue and adjusted profit rose, leaving growth uneven across its major markets. Sun Pharma's unaudited results put…

fool.com - Adria Cimino - After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?
After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?
The Motley Fool –

Eli Lilly (LLY +3.19%), as a pharma giant, offers investors a certain sense of safety in any market environment. This is because, at all times, patients need their medical treatments. But this company has also presented investors with a spectacular…

fool.com - Motley Fool Transcribing - Aptar (ATR) Q3 2026 Earnings Call Transcript
Aptar (ATR) Q3 2026 Earnings Call Transcript
The Motley Fool –

Senior Vice President, Investor Relations and Communications - Mary Skafidas President and CEO - Gael Touya Executive Vice President and CFO - Vanessa Kanu Reported Sales -- $1.02 billion, representing a 6% increase driven by broad-based growth…

businessinsider.com - Tom Carter - Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
Business Insider –

In a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy. Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious mission even by…

thenyledger.com - Press Room - Anthropic's next big AI business is life sciences, from biotech research to drug discovery
Anthropic's next big AI business is life sciences, from biotech research to drug discovery
The New York Ledger –

Anthropic conquered coding. Now it's setting its sights on the human body. Anthropic's S-1 filing, which outlines its ambitions and financials ahead of a massive initial public offering next month, reads as a life-sciences manifesto. The maker of…

ndtv.com - Abhinav Singh - Indian Biotech Startup Claims To Offer Personalised Cancer Vaccines
Indian Biotech Startup Claims To Offer Personalised Cancer Vaccines
NDTV –

PopVax launches RNA Foundry to develop personalised cancer vaccines using mRNA technology. Summary is AI-generated, newsroom-reviewed PopVax launched RNA Foundry to develop personalised cancer vaccines in Hyderabad The facility uses mRNA technology…

econotimes.com - Celia Rowan - ACE Equity Screen Cited by ETMarkets.com Puts Laurus Labs Up 21%
ACE Equity Screen Cited by ETMarkets.com Puts Laurus Labs Up 21%
EconoTimes –

An ACE Equity screen cited by ETMarkets.com placed Laurus Labs first among eight stocks in India's BSE 500 index with reported five-session gains, showing a 21% rise over the period ending Oct. 30. ETMarkets.com said roughly 18 companies in the…

fool.com - Keith Speights - 2 Stocks Billionaires Can't Stop Buying
2 Stocks Billionaires Can't Stop Buying
The Motley Fool –

If you've seen one billionaire investor's portfolio... you've seen one billionaire investor's portfolio. The super-wealthy don't always see eye to eye on where to put their money. However, that's not always the case. Here are two stocks that…

pakobserver.net - Web Desk Lahore - A look at Top Stocks at PSX as Market ends October 2026 in Red
A look at Top Stocks at PSX as Market ends October 2026 in Red
Pakistan Observer –

KARACHI – Pakistan Stock Exchange (PSX) wrapped up October 2026 under pressure, with investors witnessing turbulent trading session as the benchmark KSE-100 Index lost 784 points on Friday, October 30, wiping out part of the gains…

marketbeat.com - Top Growth Stocks To Watch Now - October 31st
Top Growth Stocks To Watch Now - October 31st
MarketBeat –

Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Teledyne Technologies, Ascendis Pharma A/S, Digital Turbine, and Jersey Mike's are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth…

thehindubusinessline.com - Nishanth  Gopalakrishnan - Big Story: Anthropic's IPO and the most defining months ahead in stock market history
Big Story: Anthropic's IPO and the most defining months ahead in stock market history
The HinduBusinessLine –

Nevertheless, here's a summary of Anthropic's business, things going for it and those that are not. Anthropic, founded in 2021, is an AI research lab that develops frontier AI models and lets customers use them for a consideration. Its products…

marketbeat.com - What Silgan (SLGN) Said on Its Q3 Earnings Call
What Silgan (SLGN) Said on Its Q3 Earnings Call
MarketBeat –

Is Consumer Discretionary a Dead End? These 3 Stocks Say No Silgan NYSE: SLGN reported third-quarter 2026 adjusted earnings per share of $1.31, up 7% from the prior-year period and at the top of its projected range, as higher operating profit and…

winterwatch.net - Russ Winter - The Biderman Report of 1956 and Covid-1984: Methods for Eliciting Individual Compliance
The Biderman Report of 1956 and Covid-1984: Methods for Eliciting Individual Compliance
Winter Watch –

In 1956, there was a study of the impacts of trauma-based mind control on Korean War prisoners detained by communists in North Korea and China. It was call the Biderman Report. Another document followed in 1961. What follows are observations from…

thehindubusinessline.com - Nishanth  Gopalakrishnan - What should investors glean from Anthropic's prospectus?
What should investors glean from Anthropic's prospectus?
The HinduBusinessLine –

Nevertheless, here's a summary of Anthropic's business, things going for it and those that are not. Anthropic, founded in 2021, is an AI research lab that develops frontier AI models and lets customers use them for a consideration. Its products…

Receive a Daily briefing on Pharma Industry News

Get Started